Expression of cyclic GMP-inbibited phosphodiesterases 3A and 3B (PDE3A and PDE3B) in rat tissues: Differential subcellular localization and regulated expression by cyclic AMP

British Journal of Pharmacology

Volumn 125, Issue 7, 1998, Pages 1501-1510

  Liu, H ^a   Maurice, D H ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Cyclic AMP; Cyclic nucleotide phosphodiesterase; Phosphodiesterase 3; Vascular smooth muscle

Indexed keywords

8 BROMO CYCLIC AMP; CYCLIC AMP; CYCLIC GMP PHOSPHODIESTERASE; ENZYME INHIBITOR; FORSKOLIN;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME LOCALIZATION; EPIDIDYMIS FAT; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE SEQUENCE; HEART; IMMUNOBLOTTING; KIDNEY; LIVER; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE;

EID: 0031737058     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702227     Document Type: Article

References (43)

1. BEAVO, J.A. (1995). Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev., 75, 725-748.
2. BOLGER, G., MICHAELI, T., MARTINS, T., ST. JOHN, T., STEINER, B., RODGERS, L., RIGGS, M., WIGLER, M. & FERGUSON, K. (1993). A family of human phosphodiesterases homologous to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs. Mol. Cell. Biol., 13, 6558-6571.
3. CALEB, B.L., HARDENBROOK, M., CHERINGTON, V. & CASTELLOT JR, JJ. (1996). Isolation of vascular smooth muscle cell cultures with altered responsiveness to the antiproliferative effect of heparin. J. Cellular Physiol., 167, 185-195.
4. CONTI, M., NEMOZ, G., SETTE, C. & VICINI, E. (1995). Recent progress in understanding the hormonal regulation of phosphodiesterases. Endocr. Rev., 16, 370-389.
5. DAVIS, C.W. & DALY, J.W. (1979). A simple direct assay of 3′,5′-cyclic nucleotide phosphodiesterase activity based on the use of polyacrylamide-bononate affinity gel chromatography. J. Cyclic Nucleotide Res., 5, 65-74.
6. DEGERMAN, E., BELFRAGE, P. & MANGANIELLO, V.C. (1997). Structure, localization, and regulation of cyclic GMP-inhibited phosphodiesterase (PDE3). J. Biol. Chem., 272, 6823-6826.
7. EKHOLM, D., HEMMER, B., GAO, G., VERGELLI, M., MARTIN, R. & MANGANIELLO, V.C. (1997). Differential expression of cyclic nucleotide phosphodiesterase 3 and 4 activities in human T cell clones specific for myelin basic protein. J. Immunology. 20, 1529.
8. ELKS, M.L., MANGANIELLO, V.C. & VAUGHAN, M. (1983). Hormone-sensitive particulate cyclic AMP phosphodiesterase activity in 3T3-L1 adipocytes. Regulation of responsiveness by dexamethasone. J. Biol. Chem., 258, 8582-8587.
9. ERDOGAN, S. & HOUSLAY, M.D. (1997). Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cyclic AMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant. Biochem. J., 321, 165-175.
10. FISHER, D.A., SMITH, J.F., PILLAR, J.S., DENIS, S.H., & CHENG, J.B. (1998). Isolation and characterization of PDE8A, a novel human cyclic AMP-specific phosphodiesterase. Biochem. Biophys. Res. Commun., 246, 570-577.
11. GRANT, P.G. & COLMAN, R.W. (1984). Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase. Biochemistry, 23, 1801-1807.
12. HARRISON, S.A., REIFSNYDER, D.H., GALLIS, B., CADD, G.G. & BEAVO, J.A. (1986). Isolation and characterization of bovine cardiac muscle cyclic GMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs. Mol. Pharmacol., 29, 506-514.
13. KASUYA, J., GOKO, H. & FUJITA-YAMAGUCHI, Y. (1995). Multiple transcripts for the human cardiac form of the cyclic GMP-inhibited cyclic AMP phosphodiesterase. J. Biol. Chem., 270, 14305-14312.
14. LEROY, M.-J., DEGERMAN, E., TAIRA, M., MURATA, T., WANG, L.-H., MOVSESIAN, M., MEACCI, E. & MANGANIELLO, V.C. (1996). Characterization of two recombinant PDE3 (cyclic GMP-inhibited cyclic nucleotide phosphodiesterase) isoforms. RcG1P1 and HcG1P2. expressed in NIH 3006 murine fibroblasts and Sf9 insect cells. Biochemistry, 35, 10194-10202.
15. LINCOLN, T.M. (1989). Cyclic GMP and mechanisms of vasodilation. Pharmac. Ther., 41, 479-502.
16. LINDGREN, S., RASCON, A., ANDERSSON, K.-E., MANGANIELLO, V.C. & DEGERMAN, E. (1991). Selective inhibition of cyclic GMP-inhibited and cyclic GMP-noninhibited cyclic nucleolide phosphodiesterases and relaxation of rat aorta. Biochem. Pharmacol., 42, 545-552.
17. LOBBERT, R.W., WINTERPACHT, A., SEIPEL, B. & ZABEL, B.U. (1996). Molecular cloning and chromosomal assignment of the human homologue of the rat cyclic GMP-inhibited phosphodiesterase I (PDE3A) a gene involved in fat metabolism located at 11p 15.1. Genomics. 37, 211-218.
18. LOUGHNEY, K. & FERGUSON, K. (1996). Identification and quantification of PDE isoenzymes and subtypes by molecular biological methods. In The Handbook of Immunopharmacology: Phosphodiesterase Inhibitors, ed. Schudt, C., Dent, G. & Rabe, K.F. Academic Press, Harcourt Brace and Company.
19. LU, Y., RAPTIS, L., ANDERSON, S., CORBLEY, M.J., ZHOU, Y.C., PROSS, H. & HALIOTIS, T. (1990). Ras modulates commitment and maturation of 10T1/2 fibroblasts to adipocytes. Biochem. Cell. Biol., 70, 1249-1257.
20. MANGANIELLO, V.C., DEGERMAN, F., TAIRA, M., KONO, T. & BELFRAGE, P. (1996). Current Topic in Cellular Regulation. 34, pp. 63-100. New York: Academic Press.
21. MANGANIELLO, V.C., MURATA, T., TAIRA, M., BELFRAGE, P. & DEGERMAN, E. (1995a). Diversity in cyclic nucleotide phosphodiesterase isoenzyme families. Arch. Biochem. Biophys., 322, 1-13.
22. MANGANIELLO, V.C., TAIRA, M., DEGERMAN, E. & BELFRAGE, P. (1995b). Type III cyclic GMP-inhibited cyclic nucleotide phosphodiesterases (PDE3 gene family). Cell. Signal., 7, 445-455.
23. MANNING, C.D. MCLAUGHLIN, M. M., LIVI, G. P., CIESLINSKI, L.B., TORPHY, T.J. & BARNETTE, M.S. (1996). Prolonged beta adrenoceptor stimulation up-regulates cyclic AMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B. J. Pharmacol. Exp. Ther., 276, 810-818.
24. MAURICE, D.H., SENIS, Y.A., LIU, H., GILES, A.R. & HORN, E.H. (1995). Cell layer-specific expression of cyclic nucleotide phosphodiesterases in rat arteries: molecular cloning using isolated cell layers from paraformaldehyde-fixed tissues. J. Pharmacol. Toxicol. Meth., 34, 175-185.
25. MCDONALD, L.J. & MURAD, F. (1996). Nitric oxide and cyclic GMP signaling. Proc. Soc. Exp. Biol. Med., 211, 1-6.
26. MEACCI, E., TAIRA, M., MOOS, JR M., SMITH, C.J., MOVSESIAN, M.A., DEGERMAN, E., BELFRAGE, P. & MANGANIELLO, V.C. (1992). Molecular cloning and expression of human myocardial cyclic GMP-inhibited cyclic AMP phosphodiesterase. Proc. Natl. Acad. Sci. U.S.A., 89, 3721-3725.
27. MURATA, T., TAIRA, M. & MANGANIELLO, V.C. (1996). Differential expression of cyclic GMP-inhibited cyclic nucleolide phosphodiesterases in human hepatoma cell lines. FEBS Letters, 390, 29-33.
28. MURRAY, K.J. (1990). Cyclic AMP and mechanisms of vasodilation. Pharmac. Ther., 47, 329-345.
29. PANG, S.C. & VENANCE, S.L. (1992). Cultured smooth muscle approach in the study of hypertension. Can. J. Physiol. Pharmacol., 70, 573-579.
30. POLSON, J.B. & STRADA, S.J. (1996). Cyclic nucleotide phosphodiesterases and vascular smooth muscle. Annu. Rev. Pharmacol. Toxicol., 36, 403-427.
31. PYNE, N.J., COOPER, M.E. & HOUSLAY, M.D. (1987). The insulin- and glucagon-stimulated 'dense-vesicle' high-affinity cyclic AMP phosphodiesterase from rat liver. Purification, characterization and inhibitor sensitivity. Biochem. J., 242, 33-42.
32. RAHN, T., RONNSTRANS, L., LEROY, M-J., WERNSTEDT, C., TORNQVIST, H., MANGANIELLO, V.C., BELFRAGE, P. & DEGERMAN, E. (1996). Identification of the site in the cyclic GMP-inhibited phosphodiesterase phosphorylated in adipocytes in response to insulin and isoproterenol. J. Biol. Chem., 271, 11575-11580.
33. RAPTIS, L., YANG, J., BROWNELL, H., LAL, J., PRESTON, T., CORBLEY, M.J., NARSIMHAN, R.P. & HALIOTIS, T. (1997). Ras(leu61) blocks differentiation of transformable 3T3 L1 and C3H10T1/2-derived preadipocytes in a dose- and time-dependent manner. Cell Growth & Differentiation. 8, 11-21.
34. RASCON, A., LINDGREN, S., STAVENOW, L., BELFRAGE, P., ANDERSSON, K.-E., MANGANIELLO, V.C. & DEGERMAN, E. (1992). Purification and properties of the cyclic GMP-inhibited cyclic AMP phosphodiesterase from bovine aortic smooth muscle. Biochim. Biophys. Acta., 1134, 149-156.
35. ROSE, R.J., LIU, H., PALMER, D. & MAURICE, D.H. (1997). Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity. Br. J. Pharmacol., 122, 233-240.
36. SHETH, S.B., BRENNAN, K.J., BIRADAVOLU, R. & COLEMAN, R.W. (1997). Isolation and regulation of the cyclic GMP-inhibited cyclic AMP phosphodiesterase in human erythroleukemia cells. Thromb. Haemostas., 77, 155-162.
37. m-cyclic GMP-inhibited cyclic AMP phosphodiesterase in mammalian myocardium. Biochem. Biophys. Res. Comm., 190, 516-521.
38. SOLDERLING, S.H., BAYUGA, S.J. & BEAVO, J.A. (1998). Identification and characterization of a novel family of cyclic nucleotide phosphodiesterase. J. Biol. Chem., 273, 15553-15558.
39. SUNAHARA, R.K., DESSAUER, C.W. & GILMAN, A.G. (1996). Complexity and diversity of mammalian adenylyl cyclases. Annu. Rev. Pharmacol. Toxicol., 36, 461-480.
40. TAIRA, M., HOCKMAN, S.C., CALVO, J.C., TAIRA, M., BELFRAGE, P. & MANGANIELLO, V.C. (1993). Molecular cloning of the rat adipocyte hormone-sensitive cyclic GMP-inhibited cyclic nucleotide phosphodiesterase. J. Biol. Chem., 268, 18573-18579.
41. TORPHY, T.J., ZHOU, H.L., FOLEY, J.J., SARAU, H.M., MANNING, C.D. & BARNETTE, M.S. (1995). Salbutamol up-regulates PDE4 activity and induces a heterologous desensitization of U937 cells to prostaglandin E2. Implications for the therapeutic use of hetaadrenoceptor agonists. J. Biol. Chem., 270, 23598-23604.
42. VERGHESE, M.W., MCCONNELL, R.T., LENHARD, J.M., HAMACHER, L. & JIN, S.-L.C. (1995). Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells. Mol. Pharmacol., 47, 1164-1171.
43. ZHAO, A.Z., ZHAO, H., TEAGUE, J., FUJIMOTO, W. & BEAVO, J.A. (1997). Attenuation of insulin secretion by insulin-like growth factor 1 is mediated through activation of phosphodiesterase 3B. Proc. Natl. Acad. Sci. U.S.A., 94, 3223-3228.